Pfizer CEO says he 'wouldn't worry much' about monkeypox; cuts drug prices for low-income countries

By CNBC
| May 25, 2022

Pfizer's CEO said Wednesday that he "wouldn’t worry much" about a recent monkeypox outbreak that has seen cases surge in non-endemic countries.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...